Cheryl CruwysFrance
Mar 9, 2024

Many breast cancer patients are facing an emergency.  Urgent help is needed. 

Enhertu, a life-extending drug for certain women with incurable HER2-low secondary breast cancer, has been rejected for use on the NHS in England.

This means thousands of women will be denied access to a drug that could’ve given them the hope of more time to live.

You can help change this.

Join the call on NICE, NHS England and the drug companies Daiichi Sankyo and AstraZeneca, to do everything possible to find a solution that makes Enhertu available on the NHS.

Please sign and share the Breast Cancer Now petition.

Help give these women back their hope.

https://action.breastcancernow.org/enhertu-emergency-sign-petition

 

Copy link
WhatsApp
Facebook
Nextdoor
Email
X